Editor’s Focus: Nearing year’s end and looking forward
DDN is evolving in all its forms, from print to online, and we look forward to unveiling it all soon
Commentary
Out of order: Sausage-making
Science is knowing you never have a complete answer and challenging any answer that arises. To the general public, however, this uncertainty rankles at a minimum and terrifies in its extreme.
Guest Commentary: RNA-seq in preclinical research and drug discovery--digging deep for insights
RNA-seq offers a comprehensive method for studying differential gene expression and changing levels of noncoding RNAs at both the single-cell and bulk sequencing levels, thus offering a powerful arsenal of investigative tools for understanding the molecular basis of disease and for the discovery and testing of new treatment options
Editor’s Focus: Alzheimer’s looms large in neuroscience
Market research suggests that neurology-related pharma and biotech R&D is going to be dominated by Alzheimer's disease for some time
Innovating scientific conferences
More meetings are going virtual, and that may very well be a good thing even after COVID is no longer a pandemic
Guest Commentary: Automation software improves speed and accuracy of cell line production
Innovative lab software automates scheduling, hit-picking and liquid transfer to boost walkaway time
Editor’s Focus: Don’t rush a vaccine
Even with caution and care, sometimes vaccination goes awry, so we need to make sure we do it right for SARS-CoV-2 and not simply do it fast
Out of order: All in?
Representation and diversity in life-sciences research matters as much in preclinical as it does in trials
Guest Commentary: A new wave of genomic medicine
A look at work to bring us medicines that target regulatory regions of the genome to control the expression of genes
Testing, testing, testing...1,2,3,4
Diagnostic testing is hotter news right now with COVID than perhaps ever before, but what does it all mean?
